News Special Report >> Immunoengineering Deep Dive: What It Is and Why It Matters to the Future of Fighting Disease In this special report, presented in part with the Immunoengineering 2021 conference and Takeda Pharmaceuticals, the Polsky Center for Entrepreneurship and Innovation explores work from across the University of Chicago...
News 16 UChicago Researchers Awarded $7.2 Million from Chan Zuckerberg Biohub Chicago The Chan Zuckerberg Biohub Chicago has funded its first cohort of Investigators at its partner institutions – including 16 researchers from the University of Chicago. The funding – a total...
Technology Diagnostic Assays And Engineered Compositions For Detecting Angiotensin II Autoantibodies And Preventing Coronavirus Autoimmunity Detection and monitoring of autoantibodies against Angiotensin II in COVID-19 patients, guiding diagnosis, treatment, and vaccine design to reduce blood pressure complications and prevent harmful autoimmune responses linked to the…
Technology Lymphangiogenesis For Therapeutic Immunomodulation A vaccine platform that uses engineered lymphangiogenesis factors and antigens to stimulate lymphatic endothelial cells, creating strong, long-lasting immune memory or tolerance with fewer side effects than traditional vaccines The…
News UChicago, Duality Teams to Pitch at 2021 Chicago Venture Summit Several teams from the University of Chicago and Duality – the world’s first accelerator focused exclusively on quantum technologies – pitched at the 2021 Chicago Venture Summit. The venture capital...
News Polsky Science and Technology Associates Helping Drive University Innovation Forward The new cohort of the Polsky Science and Technology Associates includes three University of Chicago graduate students who are working with the Polsky Center’s technology and business development teams to...
Technology New Platform For Targeted Immunomodulation And Vaccine Development There have been significant research efforts to develop effective vaccines that elicit a strong and durable T cell response against intracellular pathogens and cancer. A popular strategy has been to…
News Newest Members of the Polsky Incubator Selected The Polsky Center for Entrepreneurship and Innovation is pleased to announce the teams moving into the Polsky Incubator, which is located at the Polsky Center’s 34,000 square foot coworking space,...
News Subli, a peer-to-peer subletting marketplace, wins $25,000 at the 2020 College New Venture Challenge The Polsky Center for Entrepreneurship and Innovation at the University of Chicago is pleased to announce the winners of the 2020 College New Venture Challenge (CNVC). The CNVC is the College track of...
News Liv Labs Lands SBIR Grant and Spot in Y Combinator as it Develops a Better Tool for Women Experiencing Urinary Incontinence Urinary incontinence is a common ailment among women that often goes unspoken – and therefore untreated. One in four U.S. women, and 40% of women over age 65, experience unwelcome...
Page Third Coast Foundry Third Coast Foundry Advancing Midwest Innovation Third Coast Foundry is a new physical space in San Francisco for partner university-founded startups and teams traveling to the Bay Area. Designed to...
Technology Next-Generation Immunotherapy Platform With Engineered Collagen-Binding Cytokine Combinations Combination engineered IL-7 and IL-12 proteins that target tumors by binding to collagen, boosting immune attack on cancer while reducing side effects and improving long-term protection, even in cancers resistant…
